Second-generation Tyrosine Kinase Inhibitors Nilotinib- and Dasatinib-induced Keratosis Pilaris: A Case Report and Review of the Literature
Tyrosine kinase inhibitors (TKIs) can cause cutaneous adverse reactions, with most manifestations resembling keratosis pilaris (KP). Eleven reports describe the onset of KP, with or without confirmation through skin biopsy, during treatment with second-generation TKIs. Herein, we review the current...
Saved in:
Main Authors: | Hussein M. Alshamrani (Author), Marwan Alsaedi (Author), Hosam Alaradati (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nilotinib-Induced Keratosis Pilaris
by: Wai Mun Sean Leong, et al.
Published: (2016) -
Nilotinib Induced Keratosis Pilaris in a Female With Chronic Myeloid Leukemia
by: Ranjana Beniwal, et al.
Published: (2024) -
A case of nilotinib-induced keratosis pilaris-like perifollicular fibrosis with a brief review of the literature
by: Chih-Hao Chang
Published: (2017) -
Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib
by: Juliana Ribeiro Leitão, et al.
Published: (2016) -
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
by: Hari Krishna Ananthula, et al.
Published: (2018)